Literature DB >> 20952744

Non-antibiotics reverse resistance of bacteria to antibiotics.

J E Kristiansen1, V F Thomsen, Ana Martins, M Viveiros, L Amaral.   

Abstract

BACKGROUND: Most clinical isolates that exhibit a multi-drug resistant phenotype owe that resistance to over-expressed efflux pumps. Compounds that are efflux pump inhibitors (EPIs) reduce or reverse resistance to antibiotics to which the bacterial strain is initially resistant. We have evaluated non-antibiotics to reduce resistance of commonly encountered bacterial pathogens to antibiotics.
MATERIALS AND METHODS: The effect of non-antibiotics on the susceptibility of bacteria to antibiotics was conducted by minimum inhibition concentration determinations of the antibiotic in the absence and presence of the non-antibiotic.
RESULTS: Non-antibiotics such as chlorpromazine, amitryptiline and trans-chlorprothixene are shown to reduce or reverse resistance of a variety of bacteria to antibiotics.
CONCLUSION: The results suggest that non-antibiotics may serve as adjuncts to conventional antibiotics for the therapy of problematic antibiotic infections caused by bacteria that owe their resistance to over-expressed efflux pumps.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952744

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  21 in total

1.  Predicting the in vivo mechanism of action for drug leads using NMR metabolomics.

Authors:  Steven Halouska; Robert J Fenton; Raúl G Barletta; Robert Powers
Journal:  ACS Chem Biol       Date:  2011-12-01       Impact factor: 5.100

Review 2.  Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 3.  Lipid complexes with cationic peptides and OAKs; their role in antimicrobial action and in the delivery of antimicrobial agents.

Authors:  Raquel F Epand; Amram Mor; Richard M Epand
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

4.  Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.

Authors:  Noton K Dutta; Michael L Pinn; Petros C Karakousis
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

5.  Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.

Authors:  L Jeyaseeli; A Dasgupta; S G Dastidar; J Molnar; L Amaral
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

6.  Antibacterial and Resistance Modifying Activities of Nigella sativa Essential Oil and its Active Compounds Against Listeria monocytogenes.

Authors:  Ahmad Mouwakeh; Ágnes Telbisz; Gabriella Spengler; Csilla Mohácsi-Farkas; Gabriella Kiskó
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

7.  Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET.

Authors:  Laura R Marks; Emily A Clementi; Anders P Hakansson
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

Review 8.  RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition.

Authors:  Henrietta Venter; Rumana Mowla; Thelma Ohene-Agyei; Shutao Ma
Journal:  Front Microbiol       Date:  2015-04-28       Impact factor: 5.640

9.  Pimozide Inhibits the AcrAB-TolC Efflux Pump in Escherichia coli.

Authors:  Jürgen A Bohnert; Sabine Schuster; Winfried V Kern
Journal:  Open Microbiol J       Date:  2013-03-22

10.  Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient.

Authors:  Leonard Amaral; Joseph Molnar
Journal:  Pharmaceuticals (Basel)       Date:  2012-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.